BORTEZOMIB COMBINED WITH HISTONE DEACETYLASE INHIBITOR ITF2357 OR ARSENIC TRIOXIDE EXERTS SYNERGISTIC ANTI-PROLIFERATIVE AND PRO-APOPTOTIC EFFECTS IN P39 CELL LINE: A POSSIBLE NEW APPROACH TO HIGH-RISK MYELODYSPLASTIC SYNDROMES

Galimberti S., Canestraro M., Savli H., Palumbo G. A., Nagy B., Di Raimondo E., ...More

13th Congress of the European-Hematology-Association, Copenhagen, Denmark, 12 - 15 June 2008, vol.93, pp.495, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 93
  • City: Copenhagen
  • Country: Denmark
  • Page Numbers: pp.495
  • Kocaeli University Affiliated: Yes